Evidence map›Paper›PMID 41127005›Full record

ArticleMolecular therapy. Methods & clinical development2025

Structuring of lipid nanoparticle mRNA formulations at acidic and neutral pH: X-ray scattering and molecular dynamics studies.

Amali G Guruge, Yujia He, Andrew J Clulow, Colin W Pouton, David K Chalmers

Abstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Lipid nanoparticles for cell and gene therapy.Molecular therapy. Advances · 2026
    Article
  5. Decoding pH-Driven Phase Transition of Lipid Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amali G GurugeDepartment of Biosystems and Biotechnology, Faculty of Science, Sri Lanka Technology Campus, Ingiriya Road, Padukka 10500, Sri Lanka.
Yujia HeDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.
Andrew J ClulowDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.
Colin W PoutonDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.
David K ChalmersMedicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

mRNA lipid nanoparticles (LNPs) effectively deliver mRNA into cells. However, the structure of these particles remains poorly understood. LNP formulations are manufactured by initially forming nanoparticles at pH 4, to incorporate the RNA, then adjusting the pH 7.4 to trap the RNA within. This work investigates the structural rearrangements that occur during this process. We used the Martini 2 coarse-grained force field to model LNPs with varying water content and placement of PEGylated lipids. New parameters were developed for the lipids Dlin-MC3-DMA, its ionized form and the PEGylated lipid DMG-PEG 2000. At pH 4, the simulations suggest that bilayers are formed at the aqueous interface of the LNPs, with a largely amorphous core, whereas at pH 7.4, the bulk of the LNP is amorphous. Based on our models, we estimate that LNPs contain less than 1% w/w water, with the RNA cargo residing at the interface between water clusters and lipids. RNA entrapment is enhanced when water clusters form inside LNPs. Small-angle X-ray scattering (SAXS) measurements of LNPs at the two modeled pH values are consistent with the MD simulations. This study provides insight into water cluster formation, lipid arrangement, and RNA distribution inside LNPs, advancing our understanding of mRNA-LNP formulations.

Indexed as

formulationlipid nanoparticlesLNPsmolecular dynamicsmRNAsmall angle X-ray scattering

Identifiers

PMID41127005
PMCPMC12538909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.